Inspire Medical Systems Files 8-K

Ticker: INSP · Form: 8-K · Filed: Oct 10, 2025 · CIK: 1609550

Inspire Medical Systems, INC. 8-K Filing Summary
FieldDetail
CompanyInspire Medical Systems, INC. (INSP)
Form Type8-K
Filed DateOct 10, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: corporate-disclosure, 8-K

TL;DR

Inspire Medical Systems filed an 8-K on 10/10/25 with corporate details.

AI Summary

Inspire Medical Systems, Inc. filed an 8-K on October 10, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 5500 Wayzata Blvd., Suite 1600, Golden Valley, Minnesota, 55416, with a business phone number of (844) 672-4357. The company is incorporated in Delaware and its fiscal year ends on December 31.

Why It Matters

This 8-K filing provides essential corporate information and disclosures for Inspire Medical Systems, Inc., which is important for investors and stakeholders to stay informed about the company's operational and reporting status.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently increases risk.

Key Players & Entities

FAQ

What is the exact name of the registrant as specified in its charter?

The exact name of the registrant is Inspire Medical Systems, Inc.

On what date was this 8-K report filed?

The report was filed on October 10, 2025.

What is the principal executive office address of Inspire Medical Systems, Inc.?

The principal executive offices are located at 5500 Wayzata Blvd., Suite 1600, Golden Valley, Minnesota, 55416.

What is the telephone number of the registrant?

The registrant's telephone number is (844) 672-4357.

In which state is Inspire Medical Systems, Inc. incorporated?

The company is incorporated in Delaware.

Filing Stats: 562 words · 2 min read · ~2 pages · Grade level 9.6 · Accepted 2025-10-10 06:53:17

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. In October 2025, the Company will be participating in various meetings with investors and analysts, and a copy of the Company's presentation materials being used at these meetings is furnished as Exhibit 99.2 hereto and is incorporated herein by reference. These presentation materials are also available on the Investor Relations page of the Company's website at https://investors.inspiresleep.com. The information in Item 7.01 of this Current Report on Form 8-K and the presentation attached as Exhibit 99.2 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of Inspire Medical Systems, Inc., dated October 10, 2025. 99.2 Inspire Medical Systems, Inc. Presentation, October 10, 2025. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIRE MEDICAL SYSTEMS, INC. Date: October 10, 2025 By: /s/ Bryan K. Phillips Bryan K. Phillips Sr. Vice President, General Counsel and Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing